RYTM · NASDAQ · Biotechnology

Rhythm Pharmaceuticals (RYTM)

Markets IMCIVREE and develops MC4R agonists for rare neuroendocrine obesity disorders.

$99.27
After hours−0.16 (−0.16%)
At close$99.43(+0.60%)